EP Patent

EP3768241B1 — Topical composition comprising calcipotriol and betamethasone dipropionate

Assigned to MC2 Therapeutics Ltd · Expires 2021-09-08 · 5y expired

What this patent protects

Patent listed against Diprolene.

Drugs covered by this patent

Diprolene (BETAMETHASONE DIPROPIONATE) · Merck & Co.

Patent Metadata

Patent number: EP3768241B1
Jurisdiction: EP
Classification: —
Expires: 2021-09-08
Drug substance claim: No
Drug product claim: No
Assignee: MC2 Therapeutics Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.